• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

RASSEGNE - Reviews

Volume:

Biochimica Clinica 2014; 38(2) 092-102

Pubblicato on-line:

DOI:

Scarica in PDF:
Autenticazione richiesta

Emolisi in vivo. Parte I: classificazione

AUTORI

Franco Manzato1, Massimo Franchini2, Pier Paolo Vescovi3
1Dipartimento di Medicina di Laboratorio, 2Dipartimento di Medicina Trasfusionale ed Ematologia e 3Dipartimento Medico, Azienda Ospedaliera Carlo Poma, Mantova

ABSTRACT

In vivo hemolysis. Part I: classification

Hemolytic anemias are characterized by a reduction of the average life span of red blood cells. In some cases, the hemolysis may be massive, thus representing a life-threatening condition, which management is challenging for physicians. In other cases, hemolysis may be compensated by bone marrow stimulation or became overt only in particular conditions. From an etiologic point of view, hemolytic anemias can be divided in congenital and acquired forms. Inherited hemolytic anemias are usually diagnosed in the childhood and are due to intracorpuscolar defects (with the exception of paroxysmal nocturnal hemoglobinuria), while acquired hemolytic anemias are mainly extracorpuscolar. The prompt recognition of symptoms and a correct differential diagnosis are essential to establish a correct therapeutic approach.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967